Treatment.com AI Engages ITG for Market Making Services

Treatment.com AI has engaged Independent Trading Group (ITG) to provide market-making services, with the goal of improving liquidity of its common shares. ITG will trade shares on the CSE and other trading venues. The agreement has an initial term of one month and will renew for additional one-month terms unless terminated by either party with 30 days' notice. ITG will receive CAD $5,500 per month, payable monthly in advance, and will not receive shares or options as compensation.

Treatment.com AI Inc. (CSE: TRUE; OTC: TREIF; 939: FRA), a company utilizing AI and best clinical practices to improve the healthcare sector, has engaged Independent Trading Group (ITG) to provide market-making services. The agreement, which began on July 29, 2025, aims to enhance the liquidity of Treatment's common shares across various trading venues, including the Canadian Securities Exchange (CSE).

Under the terms of the agreement, ITG will trade shares of Treatment on the CSE and other trading venues, with the objective of maintaining reasonable market conditions and improving liquidity. The agreement has an initial term of one month, with subsequent terms automatically renewing unless either party terminates it with a 30 days' notice. ITG will receive CAD $5,500 per month as compensation, payable monthly in advance. Importantly, ITG will not receive shares or options as part of the compensation package [1].

ITG, established in 1992, is a Toronto-based CIRO dealer-member specializing in market making and liquidity provision services. The company leverages proprietary technology to deliver high-quality liquidity provision and execution services to various public issuers and institutional investors.

Treatment.com AI, through its Global Library of Medicine (GLM) platform, supports healthcare professionals by providing tested clinical information and recommended tests. The platform aims to reduce administrative burdens, create more time for patient appointments, and improve the quality of patient support, thereby addressing inefficiencies in the healthcare sector [2].

The engagement of ITG is part of Treatment's ongoing efforts to enhance its market presence and liquidity, which is crucial for attracting new investors and maintaining a stable share price. As Treatment continues to expand its healthcare AI solutions, the improved liquidity of its shares could further facilitate its growth and development.

References:
[1] https://www.stocktitan.net/news/TREIF/treatment-com-ai-engages-market-d54qny755n4s.html
[2] https://www.barchart.com/story/news/33654091/treatment-com-ai-announces-non-brokered-private-placement-of-up-to-c3-million-of-special-warrants-and-units